Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Fischl
M A
MA
University of Miami School of Medicine, Florida 33101.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003622:Dapsone / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D010419:Pentamidine / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D011799:Quinazolines / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D016597:Trimetrexate; D015215:Zidovudine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000981:Antiprotozoal Agents; D004338:Drug Combinations; D011799:Quinazolines; D015215:Zidovudine; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D003622:Dapsone; D014295:Trimethoprim; D013420:Sulfamethoxazole; D016597:Trimetrexate